HIV reservoir and chronic inflammation in men with subclinical cardiovascular disease
Introduction Atherosclerotic cardiovascular disease (CVD) is more prevalent in people with HIV-1 than in people without HIV, despite effective antiretroviral therapy (ART). The underlying reasons remain unclear. Chronic inflammation, which damages vascular endothelium and promotes plaque formation, is a major contributor to atherosclerosis. Methods In this cross-sectional, exploratory study, we investigated associations among the HIV-1 reservoir, inflammation, and subclinical atherosclerosis in men with HIV-1 (MWH) in the Pittsburgh Clinical Research Site of the Multicenter AIDS Cohort Study–Women’s Interagency HIV Study Combined Cohort Study (MWCCS). Participants had undergone cardiovascular imaging studies [ultrasound and computed tomography (CT)] and were categorized based on carotid artery ultrasound-based CVD risk stratification (age-adjusted intima-media thickness and presence of focal plaque). Results We report that MWH with greater CVD risk had higher levels of intact HIV-1 provirus. Moreover, matrix metalloproteinase 9 levels were positively associated with subclinical atherosclerosis. Single-cell RNA sequencing analysis of peripheral blood immune cells showed enrichment of MTORC1, non-canonical NF-kB, senescence-associated, monocyte state 1, and HIV-1-associated transcriptional programs in monocytes, and enrichment of interferon signaling in T cells in the high-risk carotid ultrasound group. Conclusion A higher intact HIV-1 proviral burden in this cross-sectional cohort showed associations with subclinical atherosclerosis, as well as inflammatory and senescence-associated transcriptional programs in circulating immune cells.
Authors
- Charles R. Rinaldo (ORCID: https://orcid.org/0000-0002-9194-3164)
- Jared W. Magnani (ORCID: https://orcid.org/0000-0002-5075-3604)
- Paolo Piazza (ORCID: https://orcid.org/0000-0002-3736-1841)
- Nicolas Sluis Cremer
- Arlene Bullotta
- Jorge R. Kizer (ORCID: https://orcid.org/0000-0001-9936-7803)
- Wendy S. Post (ORCID: https://orcid.org/0000-0002-8655-5204)
- Bernard J. C. Macatangay (ORCID: https://orcid.org/0000-0002-0405-0991)
- Aiymkul Ashimkhanova (ORCID: https://orcid.org/0000-0002-1159-9819)
- Yue Chen (ORCID: https://orcid.org/0000-0003-4088-7649)
- David B. Hanna (ORCID: https://orcid.org/0000-0002-1985-9865)
- Tom Medvec
- Yijia Li
- Jeremy Martinson
- Jennifer Roscher
Institutions
- Albert Einstein College of Medicine (US)
- San Francisco VA Medical Center (US)
- Johns Hopkins University (US)
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Johns Hopkins Medicine (US)
- San Francisco VA Health Care System (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fimmu.2026.1945738
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00